Ferric carboxymaltose in reducing blood transfusions and infections after cardiac surgery
Prophylactic treatment with FCM was safe but did not reduce the need for blood transfusions or postoperative infections at index hospitalization in patients without anemia undergoing cardiac surgery.
Authors
- Juhani K.E. Airaksinen (ORCID: https://orcid.org/0000-0002-0193-568X)
- Marko Vesanen
- Jarmo Gunn (ORCID: https://orcid.org/0000-0002-6996-0726)
- Markus Malmberg (ORCID: https://orcid.org/0000-0002-9955-6089)
- Kristiina Pälve (ORCID: https://orcid.org/0000-0002-6226-025X)
- Tuija Vasankari (ORCID: https://orcid.org/0000-0002-1862-8133)
- Tuomas Kiviniemi (ORCID: https://orcid.org/0000-0002-0908-3741)
- Joonas Lehto (ORCID: https://orcid.org/0000-0002-6420-8607)
- Vesa Anttila (ORCID: https://orcid.org/0000-0001-7108-1141)
Institutions
- University of Turku (FI)
- Turku University Hospital (FI)
Publication Details
- Journal
- JTCVS Open
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1016/j.xjon.2024.09.009
- Citations
- 1
- Primary Topic
- Blood transfusion and management
- Type
- article
- Field-Weighted Citation Impact
- 0.22
Funders
- Vifor Pharma